Cormorant Asset Management’s 4D Molecular Therapeutics FDMT Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-200,000	Closed	-$8.68M	–	109
2021 Q1	$8.68M	Hold	200,000	–	–	0.19%	73
2020 Q4	$8.29M	Buy	+200,000	New	+$8.29M	0.2%	68